Class IIOngoingD-0575-2025
Drug recall · August 20, 2025
Levoxyl recall
Why: Subpotent drug
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Levoxyl (levothyroxine sodium tablets, USP), 50 mcg, 100-count bottle, Rx only, Distributed by: Pfizer Inc., New York, NY 10017, Made in Austria, NDC 60793-851-01.
- Lots / codes
Lot #: 24C11, Exp 2/28/2026.
- Quantity
- 29, 004 bottles
- Company
- Pfizer, Manhattan, NY
- Distribution
- Within U.S
- Initiated
- July 29, 2025 · Voluntary: Firm initiated
- Classified
- August 8, 2025
- Reported
- August 20, 2025
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Levoxyl
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.